NeuroMagen Logo.png

Our goal is to bring to market a new breakthrough drug to treat ALS patients which will significantly delay the onset, and the progression, of this horrible disease, and hopefully improve and extend patients’ lives. 

Our Story

We are developing a new class of drugs for neurodegenerative diseases. 

We have assembled a top-notch team of experienced professionals, including 3 PhD’s and a  chemical engineer to develop the breakthrough drug.

Telomerase is an enzyme which increases cell lifespan and participates in the cells protection mechanism.  
NeuroMagen's novel drug boosts the telomerase operation as neuroprotector and can be used to delay the onset and progression of ALS.

Meet The Team